title: Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
authors.forename: J
authors.initials: J
authors.lastname: Graham-Pole
authors.forename: M
authors.initials: M
authors.lastname: Ayass
authors.forename: W
authors.initials: W
authors.lastname: Cassano
authors.forename: N
authors.initials: N
authors.lastname: Dickson
authors.forename: W
authors.initials: W
authors.lastname: Enneking
authors.forename: M
authors.initials: M
authors.lastname: Heare
authors.forename: T
authors.initials: T
authors.lastname: Heare
authors.forename: R
authors.initials: R
authors.lastname: Marcus
authors.forename: R
authors.initials: R
authors.lastname: Saleh
authors.forename: S
authors.initials: S
authors.lastname: Spanier
mesh_terms: D000671:Amputation, Surgical; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005431:Florida / Q000453:epidemiology; D006801:Humans; D007261:Infusions, Intra-Arterial; D007262:Infusions, Intravenous; D015993:Life Tables; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary; D008727:Methotrexate / Q000008:administration & dosage; D012516:Osteosarcoma / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000556:secondary / Q000601:surgery / Q000628:therapy*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D008727:Methotrexate